AKTX

Akari Therapeutics
AKTX

19 hedge funds and large institutions have $6.34M invested in Akari Therapeutics in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
19
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$571K
2
+$395K
3
+$51.8K
4
Citadel Advisors
Citadel Advisors
Florida
+$36.6K
5
Squarepoint
Squarepoint
New York
+$36.6K

Top Sellers

1
-$24K
2
-$9.14K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$3.27M
2
$986K
3
$854K
4
$654K
5
$291K
6
$59K
7
$41K
8
$41K
9
$40K
10
$29K
11
$26K
12
$26K
13
$7K
14
$5K
15
$4K
16
$2K
17
$2K
18
$2K
19
$1K
20
–